Intensive treatment and severe hypoglycemia among adults with type 2 diabetes
Open accessAbstract
IMPORTANCE: Intensive glucose-lowering treatment among patients with non-insulin-requiring type 2 diabetes may increase the risk of hypoglycemia. OBJECTIVES: To estimate the prevalence of intensive treatment and the association between intensive treatment, clinical complexity, and incidence of severe hypoglycemia among adults with type 2 diabetes who are not using insulin. DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of administrative, pharmacy, and laboratory data from the OptumLabs Data Warehouse from January 1, 2001, through December 31, 2013. The study included nonpregnant adults 18 years or older with type 2 diabetes who achieved and maintained a hemoglobin A1c (HbA1c) level less than 7.0% without use of insulin and had no episodes of severe hypoglycemia or hyperglycemia in the prior 12 months. MAIN OUTCOMES AND MEASURES: Risk-adjusted probability of intensive treatment and incident severe hypoglycemia, stratified by patient clinical complexity. Intensive treatment was defined as use of more glucose-lowering medications than recommended by practice guidelines at specific index HbA1c levels. Severe hypoglycemia was ascertained by ambulatory, emergency department, and hospital claims for hypoglycemia during the 2 years after the index HbA1c test. Patients were categorized as having high vs low clinical complexity if they were 75 years or older, had dementia or end-stage renal disease, or had 3 or more serious chronic conditions. RESULTS: Of 31 542 eligible patients (median age, 58 years; interquartile range, 51-65 years; 15 483 women [49.1%]; 18 188 white [57.7%]), 3910 (12.4%) had clinical complexity. The risk-adjusted probability of intensive treatment was 25.7% (95% CI, 25.1%-26.2%) in patients with low clinical complexity and 20.8% (95% CI, 19.4%-22.2%) in patients with high clinical complexity. In patients with low clinical complexity, the risk-adjusted probability of severe hypoglycemia during the subsequent 2 years was 1.02% (95% CI, 0.87%-1.17%) with standard treatment and 1.30% (95% CI, 0.98%-1.62%) with intensive treatment (absolute difference, 0.28%; 95% CI, -0.10% to 0.66%). In patients with high clinical complexity, intensive treatment significantly increased the risk-adjusted probability of severe hypoglycemia from 1.74% (95% CI, 1.28%-2.20%) with standard treatment to 3.04% (95% CI, 1.91%-4.18%) with intensive treatment (absolute difference, 1.30%; 95% CI, 0.10%-2.50%). CONCLUSIONS AND RELEVANCE: More than 20% of patients with type 2 diabetes received intensive treatment that may be unnecessary. Among patients with high clinical complexity, intensive treatment nearly doubles the risk of severe hypoglycemia.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · see citing works
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578 · see citing works
Using the Margins Command to Estimate and Interpret Adjusted Predictions and Marginal Effects
Williams, R. A. (2012) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x1201200209 · Cited by 2,193 · see citing works
Emergency hospitalizations for adverse drug events in older Americans.
Budnitz, D., Lovegrove, M., Shehab, N., & Richards, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1103053 · Cited by 1,748 · see citing works
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471 · see citing works
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428 · see citing works
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370 · see citing works
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189 · see citing works
Gerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981 · see citing works
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933 · cited 1× · see citing works
“The association between intensive treatment and severe hypoglycemia was examined in a second logistic regression model in which the main predictor was a 4-level measure of patient complexity and treatment intensity: (1) low complexity with standard treatment, (2) low complexity with intensive treatment, (3) high compl…”
MethodDiabetes in Older Adults: A Consensus Report
Sue Kirkman, M., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12035 · Cited by 548 · see citing works
Huang, E. S., Laiteerapong, N., Liu, J. Y., John, P. M., Moffet, H. H., & Karter, A. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12956 · Cited by 501 · see citing works
Optum Labs: Building A Novel Node In The Learning Health Care System
Wallace, P. J., Shah, N. D., Dennen, T., Bleicher, P. A., & Crown, W. H. (2014) · Health Affairs · doi:10.1377/hlthaff.2014.0038 · Cited by 449 · see citing works
Self-citationPotential overtreatment of diabetes mellitus in older adults with tight glycemic control
Lipska, K. J., Ross, J. S., Miao, Y., Shah, N. D., Lee, S. J., & Steinman, M. A. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7345 · Cited by 408 · see citing works
Self-citationLipska, K. J., Ross, J. S., Wang, Y., Inzucchi, S. E., Minges, K. E., Karter, A. J., Huang, E. S., Desai, M. M., Gill, T. M., & Krumholz, H. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1824 · Cited by 390 · see citing works
Self-citationClinical Inertia in Response to Inadequate Glycemic Control
Shah, B. R., Hux, J. E., Laupacis, A., Zinman, B., & van Walraven, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.600 · Cited by 387 · see citing works
Geller, A. I., Shehab, N., Lovegrove, M. C., Kegler, S. R., Weidenbach, K. N., Ryan, G. J., & Budnitz, D. S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.136 · Cited by 311 · see citing works
Type 2 Diabetes in Adults: Management
Internal Clinical Guidelines Team (2015) · Cited by 300 · see citing works
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
Moneta, G. L. (2009) · Yearbook of Vascular Surgery · doi:10.1016/s0749-4041(08)79023-7 · Cited by 242 · see citing works
Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
Ginde, A. A., Blanc, P. G., Lieberman, R. M., & Camargo, C. A. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-4 · Cited by 234 · see citing works
AACE/ACE comprehensive diabetes management algorithm 2015
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., Davidson, M. B., Einhorn, D., Garber, J. R., et al. (2015) · Endocrine Practice · doi:10.4158/ep15693.cs · Cited by 225 · see citing works
National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
Alexander, G. C., Sehgal, N. L., Moloney, R., & Stafford, R. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2088 · Cited by 224 · see citing works
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 216 · see citing works
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
(2009) · New England Journal of Medicine · doi:10.1056/nejmx090034 · Cited by 200 · see citing works
Workgroup, A. C. W. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12226 · Cited by 191 · see citing works
Vijan, S., Sussman, J. B., Yudkin, J. S., & Hayward, R. A. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.2894 · Cited by 185 · see citing works
Greenfield, S., Billimek, J., Pellegrini, F., Franciosi, M., Berardis, G. D., Nicolucci, A., & Kaplan, S. H. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-12-200912150-00005 · Cited by 170 · see citing works
Assessing Potential Glycemic Overtreatment in Persons at Hypoglycemic Risk
Tseng, C., Soroka, O., Maney, M., Aron, D. C., & POGACH, L. M. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12963 · Cited by 161 · see citing works
Sussman, J. B., Kerr, E. A., Saini, S. D., Holleman, R. G., Klamerus, M. L., Min, L. C., Vijan, S., & Hofer, T. P. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.5110 · Cited by 160 · see citing works
Duckworth, W. C., Abraira, C., Moritz, T. E., Davis, S. N., Emanuele, N., Goldman, S., Hayward, R., Huang, G. D., Marks, J. B., Reaven, P. D., et al. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.10.003 · Cited by 152 · see citing works
Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012
Turner, L. W., Nartey, D., Stafford, R. S., Singh, S., & Alexander, G. C. (2013) · Diabetes Care · doi:10.2337/dc13-2097 · Cited by 136 · see citing works
Racial and Ethnic Disparities among Enrollees in Medicare Advantage Plans
Ayanian, J. Z., Landon, B. E., Newhouse, J. P., & Zaslavsky, A. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmsa1407273 · Cited by 130 · see citing works
Berard, L., Blumer, I. R., Houlden, R. L., Miller, D. B., & Woo, V. C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.017 · Cited by 98 · see citing works
Workgroup, A. C. W. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12770 · Cited by 91 · see citing works
McCoy, R. G., Houten, H. K. V., Ross, J. S., Montori, V. M., & Shah, N. D. (2015) · BMJ · doi:10.1136/bmj.h6138 · Cited by 62 · see citing works
Self-citationDiabetes Oral Medication Initiation and Intensification
Grant, R. W., Pabon-Nau, L. P., Ross, K. M., Youatt, E. J., Pandiscio, J. C., & Park, E. R. (2010) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721710388427 · Cited by 54 · see citing works
Horowitz, K. R., Miller, M. E., Kimel, A. R., et al. (2021) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/8744-6952 · Cited by 44 · see citing works
Racial comparisons of diabetes care and intermediate outcomes in a patient-centered medical home
Simonetti, J. A., Fine, M. J., Chen, Y.-F., Simak, D., & Hess, R. (2014) · Diabetes Care · doi:10.2337/dc13-1332 · Cited by 19 · see citing works
Siebe, C. (2014) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2014.06.006 · Cited by 16 · see citing works
Changing trends in type 2 diabetes mellitus treatment intensification, 2002-2010.
McCoy, R. G., Zhang, Y., Herrin, J. S., Denton, B. T., Mason, J. E., Montori, V. M., Smith, S. A., & Shah, N. D. (2015) · PubMed · Cited by 9 · see citing works
Self-citationAssessing Potential Glycemic Overtreatment in Persons at Hypoglycemic Risk
Tseng, C., Soroka, O., Maney, M., et al. (2014) · Survey of Anesthesiology · doi:10.1097/sa.0000000000000099 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623 · see citing works
Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013
Lipska, K. J., Yao, X., Herrin, J., McCoy, R. G., Ross, J. S., Steinman, M. A., Inzucchi, S. E., Gill, T. M., Krumholz, H. M., & Shah, N. D. (2017) · Diabetes Care · doi:10.2337/dc16-0985 · Cited by 306 · see citing works
Self-citationSilbert, R., Salcido-Montenegro, A., Rodriguez-Gutierrez, R., Katabi, A., & McCoy, R. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1018-0 · Cited by 229 · see citing works
Self-citationHaak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0255-6 · Cited by 188 · see citing works
Yu, B., Li, C., Sun, Y., & Wang, D. W. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.014 · Cited by 148 · see citing works
Karter, A. J., Warton, E. M., Lipska, K. J., Ralston, J. D., Moffet, H. H., Jackson, G. G., Huang, E. S., & Miller, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3844 · Cited by 150 · see citing works
Self-citationDiagnosis and Treatment of Type 2 Diabetes in Adults
Kalyani, R. R., Neumiller, J. J., Maruthur, N. M., & Wexler, D. J. (2025) · JAMA · doi:10.1001/jama.2025.5956 · Cited by 145 · see citing works
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.19099 · Cited by 141 · see citing works
Self-citationGlycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
Zhou, J. J., Schwenke, D. C., Bahn, G., & Reaven, P. (2018) · Diabetes Care · doi:10.2337/dc18-0548 · Cited by 131 · see citing works
Andreozzi, F., Candido, R., Corrao, S., Fornengo, R., Giancaterini, A., Ponzani, P., Ponziani, M. C., Tuccinardi, F., & Mannino, D. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00559-7 · Cited by 128 · see citing works
Karter, A. J., Lipska, K. J., O’Connor, P. J., Liu, J. Y., Moffet, H. H., Schroeder, E. B., Lawrence, J. M., Nichols, G. A., Newton, K. M., Pathak, R. D., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.009 · Cited by 53 · see citing works
Makam, A. N., & Nguyen, O. K. (2017) · Circulation · doi:10.1161/circulationaha.116.022622 · Cited by 52 · see citing works
Misra-Hebert, A. D., Pantalone, K. M., Ji, X., Milinovich, A., Dey, T., Chagin, K. M., Bauman, J. M., Kattan, M. W., & Zimmerman, R. S. (2018) · Diabetes Care · doi:10.2337/dc17-1834 · Cited by 46 · see citing works
Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes
McCoy, R. G., Herrin, J., Lipska, K. J., & Shah, N. D. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.04.007 · Cited by 40 · see citing works
Self-citationLega, I. C., Campitelli, M. A., Austin, P. C., Na, Y., Zahedi, A., Leung, F., Yu, C., Bronskill, S. E., Rochon, P. A., & Lipscombe, L. L. (2021) · Diabetologia · doi:10.1007/s00125-020-05370-7 · Cited by 40 · see citing works
Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12 · see citing works
Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial
Grant, R. W., Peterson, I., McCloskey, J. M., Lipska, K. J., Nugent, J., Karter, A. J., & Gilliam, L. K. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.2015 · Cited by 11 · see citing works
Self-citation
- Authors
- McCoy, R. G., Lipska, K. J., Yao, X., Ross, J. S., Montori, V. M., & Shah, N. D.
- Affiliations
- Mayo Clinic (US)
- Yale University (US)
- Division of Endocrinology Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota9Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota
- Corresponding author
- McCoy, Rozalina G.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2016-07-01
- Volume
- 176
- Issue
- 7
- Pages
- 969
- ISSN
- 2168-6106 (ISSN-L)
- PMC
- PMC5380118
- OpenAlex
- W2413896585
- Cited by
- 143
- References
- 43
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 16 · 2021: 9 · 2020: 15 · 2019: 21 · 2018: 15 · 2017: 20 · 2016: 8 · 2015: 1
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- Agency for Healthcare Research and Quality (R18HS018339)
- National Institute on Aging (K23AG048359, P30AG021342)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Emergency Medical Services › Patient Safety and Medication Errors
- Keywords
- type 2 diabetes, severe hypoglycemia, clinical complexity, HbA1c, glucose-lowering medications, older adults, end-stage renal disease, dementia, comorbidities, hypoglycemia risk, glycemic control, hyperglycemia, risk adjustment
- MeSH terms
- Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Patient Care Management, Retrospective Studies, Risk Factors, United States, Comorbidity, Prevalence, Drug Monitoring, Risk Adjustment, Needs Assessment, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
